← All indications
Lymphopenia
Reduction in the number of lymphocytes.
Subtype terms (2)
More specific conditions that are subtypes of Lymphopenia in the MeSH hierarchy.
- T-Lymphocytopenia, Idiopathic CD4-Positive
4 drugs (3 approved, 1 experimental)
- Wiskott-Aldrich Syndrome
34 drugs (26 approved, 8 experimental)
Drugs by status
Organizations
Organization Involved with Phase 2 Indications (17)
- Accentia Biopharmaceuticals
- Constant Pharmaceuticals
- Cytheris
- National Institute of Allergy and Infectious Diseases (NIAID)
- Centre Leon Berard
- University of London
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- Universidad Autonoma de Madrid
- University of Valencia
- US Biotest
- University of Limoges
- Washington University in St. Louis
- Amarex Clinical Research
- Government of France
- Memorial Sloan-Kettering Cancer Center
- Miguel Hernández University
- Biocruces Bizkaia Health Research Institute
Organization Involved with Phase 1 Indications (5)
Organization Involved with Other Experimental Indications (2)